Health-related quality of life in Chinese children with immune thrombocytopaenia: a multicentre study

• by Shuxian Huang, Min Chen, Hui Zhang, Yongzhi Zheng, Sihan Huang, Zhiyuan Chen, Jinhong Luo, Liyun Xiao, Jinhua Chu, Biyun Guo, Yan Dai, Yuantao Huang, Shuhong Shen, Haixia Zhou, Kaizhi Weng

• April 1, 2026

Unexpected genetically determined immune dysregulation with liver involvement: GIMAP5 therapeutic dilemmas between targeted therapy and HSCT

• by Mattia Moratti, Michele La Manna, Lucia Colucci, Cristina Cifaldi, Silvia Di Cesare, Gioacchino Andrea Rotulo, Beatrice Rivalta, Donato Amodio, Andrea Pietrobattista, Andrés Caballero-Oteyza, Elisabetta Lembo, Chiara Passarelli, Emma Concetta Manno, Michele Proietti, Gigliola Di Matteo, Giuseppe Palumbo, Caterina Cancrini

• June 10, 2026

Digital Twins for Rare Diseases

AI-driven models address data gaps in rare disease research and diagnostics

• April 20, 2026

• 5 min

Can a BiTE Immunotherapy Improve Survival in Young Patients with High-Risk Kinase-Driven B-ALL Subtypes?

Two genetic subtypes of childhood B-cell acute lymphoblastic leukemia (B-ALL) have long been associated with inferior treatment outcomes: Philadelphia chromosome-positive (Ph+) and ABL-class Philadelphia chromosome-like (Ph-like) B-ALL.

• January 29, 2026

• 3 min